Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Jun 13;19(6):e0305767. doi: 10.1371/journal.pone.0305767

Correction: Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease

The PLOS ONE Staff
PMCID: PMC11175472  PMID: 38870254

Notice of Republication

This article was republished on June 5, 2024, to correct for column and line duplication in Table 3 introduced during the typesetting process. Please download this article again to view the correct version.

Supporting information

S1 File. Originally published, uncorrected article.

(PDF)

pone.0305767.s001.pdf (1.7MB, pdf)
S2 File. Republished, corrected article.

(PDF)

pone.0305767.s002.pdf (1.8MB, pdf)

Reference

  • 1.Petra E, Siwy J, Vlahou A, Jankowski J (2022) Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease. PLoS ONE 17(1): e0262667. 10.1371/journal.pone.0262667 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Originally published, uncorrected article.

(PDF)

pone.0305767.s001.pdf (1.7MB, pdf)
S2 File. Republished, corrected article.

(PDF)

pone.0305767.s002.pdf (1.8MB, pdf)

Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES